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Frequency of silent myocardial ischaemia in diabetics: a single centre study
Adil Sheikh, Syed Shah Faisal, Abdul Jabbar
Department of Medicine, Aga Khan University, Karachi.
Abstract
Objective: To find the frequency of silent myocardial ischaemia in diabetics as compared to non-diabetics. 
Methods: This was a cross sectional study conducted between November 2008 and March 2010. Two hundred
subjects were recruited by convenience sampling after informed cnosent. All were subjected to an exercise stress test.
Electro-cardiographic changes were noted for silent Ischaemia Descriptive Statistics were applied for significance.
Result: Of the 200 subjects included in the study, 31 had diabetes and 1`69 were non-diabetics. The mean age
was 46±10 years. Twenty eight subjects tested positive for silent ischaemia, of whom six were diabetics(19%)
and 22 were non-diabetics(13%).Hypertension and obesity were found more frequently in diabetics (48% Vs
27%) p=0.019 and (35% Vs 18%) p=0.027 respectively. 
Despite the greater proportion of diabetics having asymptomatic myocardial ischaemia as compared to non-
diabetics statistical significance(p = 0.397) was not observed.
Conclusion: There was no significant difference in the frequency of silent ischaemia amongst the two groups. 
Keywords: Exercise test, Ischaemia, Diabetes Mellitus, Hypertension, Obesity (JPMA 61:1037; 2011).
Introduction
Diabetes Mellitus is a well established risk factor for
coronary heart disease. Sudden cardiac death or acute
coronary events are twice as common in diabetics compared
to non- diabetics.1 Cardiovascular complications are a major
cause of mortality , accounting for 65% to 85% deaths in the
diabetic population.2 The cardiovascular prognosis is worse
in diabetics compared to non diabetics with cardiovascular
disease - so much so that diabetes has been labeled as a
'coronary heart disease equivalent.'3 Not only is coronary
heart disease more extensive in diabetics but it also has an
atypical presentation with myocardial ischaemia not
manifesting with pain in a significant proportion of cases.4
Silent myocardial ischaemia has always been a poorly
understood clinical entity. The cause of silent ischaemia has
often been attributed to autonomic neuropathy arising in
diabetes mellitus.5 It has been postulated that a combination
of abnormalities in the sympathetic and parasympathetic
pathways may be responsible.6 However paradoxical
findings of presence of silent myocardial infarction in
diabetics without neuropathy and presentation of angina in
diabetics have also been made.4,7 The reported prevalence of
silent myocardial ischaemia in diabetic patients, as observed
in many clinical studies has been found to be ranging between
20%-50% and has been higher than non diabetics. However
in retrospect some authors do not report any significant
difference in the finding of silent ischaemia when diabetic
patients were compared to non-diabetic subjects.4,5,8,9
It has been reported that silent myocardial ischaemia
(SMI) is not different from symptomatic Coronary Artery
Disease with respect to the ischaemic insult and acute
coronary events or sudden cardiac death later on.1,7
Objectively SMI has been labeled as a predictor of severe
coronary heart disease10 with 40-90% patients having SMI
showing evidence of coronary artery stenosis on
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angiography.3 Evidence suggests that individuals having co-
morbidity with type 2 diabetes present in association with
other coronary risk factors and are more likely to have silent
myocardial ischaemia.3,11,12 Therefore in patients having
type 2 diabetes mellitus and a coronary risk factor profile an
aggressive diagnostic and therapeutic approach is
warranted13 since they are known to develop accelerated
coronary artery disease. The importance of coronary risk
factors in developing coronary artery disease has been
highlighted by De Luca et al.11 who observed that episodes
of silent myocardial ischaemia increased in both diabetic
and non-diabetic subjects if two or more coronary risk
factors were present. 
Literature regarding the finding of silent myocardial
ischaemia in Asian diabetic patients has been scarce.
Differing prevalence of SMI in previous studies has been
explained by different characteristics of study population in
each setting.4 This study was conducted in a single centre,
describing and comparing the frequency of Silent
Myocardial Ischaemia in diabetics and non-diabetics going
through a screening Exercise Stress Test. Our primary
objective was to compare frequency of silent myocardial
ischaemia in diabetics and non-diabetics. 
Patients and Methods
In this cross sectional study, two Hundred patients
were prospectively recruited in the Cardiopulmonary
Department of Aga Khan University Hospital (AKUH) for
health screening to assess their functional capacity by
exercise stress test. AKUH is a tertiary care hospital which
caters to wide variety of patient population in the urban
metropolis of Karachi, the largest city and commercial hub
of the country. 
This study was conducted between the period
spanning from November 2008 to March 2010, with data
collection being completed by January 2010. Convenience
sampling was applied and sampling size was calculated
using Sample Size Determination in Health Studies software
provided by the World Health Organization. Using an
anticipated population proportion of 15%14 for silent
myocardial ischaemia, with an absolute precision of 5% with
95% confidence interval, the sample size calculated was 196.
To be included in the study, respondents had to be
physically fit for exercise with a normal resting (baseline)
ECG with no prior history of coronary heart disease.
Informed consent was obtained before inclusion in the study. 
Exclusion criteria applied were to subjects with a
positive history of coronary heart disease, with symptoms of
angina, subjects taking digoxin or beta blockers, subjects with
a permanent pacemaker and those who were physically
disabled or unable to take a stress test. Subjects with resting
systolic blood pressure values greater than 200mm Hg and
abnormal baseline ECG changes like ST-segment depression,
right or left bundle branch block were also excluded.
After taking formal consent - patients' weight,
height, pulse, respiratory rate and blood pressure were
measured. Laboratory investigations for haemoglobin and
lipid profile (HDL, LDL and total cholesterol) were
estimated. Urine analysis was done for proteinuria. Twelve
(12) lead resting ECG (baseline) was also done in all
subjects and assessed for any abnormal changes.
Prior to exercise testing, each recruited patient
underwent a structured history and medical record review to
document co-morbidities and relevant past medical history.
A questionnaire was used for documentation of major
coronary risk factors including history of hypertension,
dyslipidaemia, previous myocardial infarction or acute
coronary events, any coronary interventional procedures
(revascularization or angioplasty), diabetes mellitus-
including duration of disease and mode of treatment used,
obesity, family history of coronary heart disease and
smoking habits. 
Hypertension was defined according to the Joint
National Committee Guidelines,15 as a systolic blood
pressure of 140 mmHg or higher, a diastolic blood pressure
of 90 mmHg or more, or the use of antihypertensive
medication.In respondents who were diabetic, hypertension
was defined as a systolic blood pressure greater than 130
mm of Hg and diastolic pressure above 80 mm of Hg.
Hyperlipidaemia was defined as a total cholesterol level of
200 mg/dl (5.18 mmol /l) or higher or the use of lipid-
lowering drugs. Diabetes was defined by blood glucose
levels either a fasting blood glucose >126mg/dl or random
glucose >200mg/dl. 
Electrocardiogram changes were assessed among
respondents undergoing an exercise stress test (E.S.T) to
look out for ischaemic changes in otherwise asymptomatic
subjects without any prior evidence of coronary heart
disease. The E.S.T was done on a Precor® treadmill after
demonstration to all subjects. Bruce protocol was used. At
the end of each stage blood pressure and ECG tracings were
recorded. ECG was also taken at peak of exercise and
immediately after the end of exercise. Exercise endpoints
are summarized in Table-1.
During recovery ECG and blood pressure was
monitored three times; two minutes , five minutes and ten
minutes after completion of EST. Maximal ST - segment
change at 80 milliseconds after the J-point was assessed on
ECG tracings. Horizontal or downsloping ST -segment
depression of at least 1mm or up sloping of 1.5mm or more
was considered a positive test result for silent myocardial
ischaemia. The electrocardiographic criteria for silent
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myocardial ischaemia has been extensively used in other
patient cohorts undergoing an E.S.T.16
The data set was stored and data entries were
verified against the primary data, confidentiality of record
was ensured by keeping the data on a single desktop
computer system.
SPSS version 17.0 was used to analyze the data.
Descriptive statistics, chi-square and students T-test was
used for statistical calculations. Statistical significance was
considered with a p-value < 0.05.
Results
The two hundred respondents comprised of one-
hundred and seventy (170) males and thirty (30) females.
Sample age ranged from 30 years to 76 years with a mean
age of 46 ±10 years.
Thirty one out of two hundred subjects (16%) were
diabetic and one hundred and sixty nine (84%) were non-
diabetic. The diabetic group comprised of twenty-three (23)
males and eight (8) females. 
Coronary risk factor profile for the 200 subjects in
the study is summarized in Table 2.
When these risk factors were compared in diabetic
and non-diabetic groups only hypertension and obesity were
found more frequently in diabetics (48% Vs 27%) p=0.019
and (35% Vs 18%) p=0.027 respectively. The frequency of
other risk factors in both the groups showed no major bias-
69(34%) respondents had a history of smoking, 94(47%)
had a family history of coronary artery disease. Lipid profile
revealed total cholesterol ranging from108mg/dl to
318mg/dl (mean 196±28).
Total time consumed by subjects during EST ranged
from two minutes to eighteen (18) minutes. METS was from
2 to 19. Among 200 subjects 42 (21%) achieved 100%
maximum predicted heart rate and 31 (16%) achieved < 85%
of maximum predicted heart rate and 127 (63%) achieved
between 85 to 99%. Blood pressure response of exercise was
normal in 166 (83%) and hypertensive in 34 (17%). 
Results are categorized and summarized in Table-3.
The twenty-eight subjects who had silent myocardial
ischaemia comprised of 6(19%) diabetic patients and
22(13%) non-diabetic patients.. Despite the greater
proportion of diabetics having asymptomatic myocardial
ischaemia as compared to non-diabetics, the result which
was not statistically significant. (p = 0.397).
Discussion
Diabetes mellitus is a well known risk factor for
coronary heart disease. Diabetics have been observed to
have more extensive coronary heart disease17,18 and it is
generally believed that myocardial ischaemia is often
asymptomatic.9,19-21 The reported frequency of silent
myocardial ischaemia in diabetics is variable with some
studies reporting it as the same in non-diabetics.5,9,22,23 Our
study results are in line with findings of Caraccilo,5 Chipkin
et al22 and Airaksinen et al,8 with no significant difference
in silent myocardial ischaemia in diabetics and non
diabetics (19% vs 13%). Amongst reasons for asymptomatic
myocardial ischaemia other than autonomic neuropathy are
mechanisms, such as the intensity of the stimulus,
differences in pain threshold, a defective anginal warning
system and ischaemic damage to nerve endings.4
There is divided opinion regarding the screening of
diabetic patients for heart disease and silent ischaemia.
Presently non invasive screening methods are recommended
for the group of diabetic patients who have a significant
coronary risk factor profile i.e having two or more risk
factors.11 Non invasive screening methods include Exercise
Stress Test, stress Myocardial Perfusion Imaging ,Cardiac
Computed tomography and dobutamine stress
echocardiography and all have helped to various degrees in
early detection of heart disease- which is vital for favourable
outcomes and prevention of acute cardiac events. Despite
their diagnostic value screening methods add to direct and
indirect health care costs for the patient and understandably
there have been calls to improve screening strategy-by
limiting screening for silent ischaemia in diabetic patients
with high coronary artery disease risk.3,24
An exercise stress test was used for screening of
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Table-1: Exercise endpoints.
Physical exhaustion
Severe angina
Sustained ventricular tachycardia
Exertional hypotension
Supraventricular arrhythmias
Exertional hypertension (systolic > 250mmhg)
Table-2: Coronary risk factor profile for study sample.
Hypertensive 98(49%)
Dyslipidaemia 61(30%)
Positive Family History for CAD 94 (47%)
Obesity(BMI > 30 kg/m2) 41(20%)
Smoking habit 69(34%)
Table-3: Results for EST in study subjects.
Negative for exercise induced reversible
myocardial ischaemia 150 (75%)
Positive for asymptomatic exercise
induced reversible myocardial ischaemia 28 (14%)
Positive for symptomatic exercise induced
reversible myocardial ischaemia 7 (3.5%)
Test was inconclusive (due to reasons in table 2.2) 15 (7.5%)
subjects for silent myocardial ischaemia in the presented
study, since it is a safe, inexpensive and non invasive
screening test.25-28 Along with the mentioned attributes, the
real advantage of using the exercise tolerance test lies in its
high negative predictive value.7,25 Even though false
positive results in exercise testing for silent ischaemia have
been reported, the chances of a false positive result in
asymptomatic population with coronary risk factors is
low.10 Moreover it has been shown that the positive
predictive value of EST, in screening silent ischaemia
increases if two or more cardiac risk factors are present.25
Thereby justifying our use of exercise tolerance test as a
screening tool since it is seldom negative in patients with
silent myocardial ischaemia.
The clinical significance of silent myocardial
ischaemia is similar to that of symptomatic cardiac
ischaemia. Prospective studies have shown that patients
with silent myocardial ischaemia have an increased risk of
acute coronary events,29 even though the extent of
ischaemia is similar to that in symptomatic ischaemic heart
disease. Patients with silent ischaemia are given less
cardioprotective treatment and revascularization due to the
latent presentation.30 The American Diabetes Association
has recommended that diabetic patients along with two or
more coronary risk factors must be screened for silent
myocardial ischaemia for diagnosing early cardiovascular
disease.31,32 As our results suggest no significant difference
in frequency of silent myocardial ischaemia between
diabetics and non-diabetics (19% vs 13%) despite of higher
prevalence of hypertension and obesity in the diabetic
group-again this creates an argument for those questioning
the need and criteria for screening recommendations.
It has been shown that silent myocardial ischaemia is
a strong predictor for coronary heart disease in patients with
an unfavourable risk factor profile.7,10 49% of our total
study sample had hypertension. Amongst the diabetic group
of 31 subjects 48% had hypertension compared with 27% of
hypertensive patients in the non-diabetic group. Also 35%
of the diabetics were obese compared to 18% in the non
diabetic group. Other coronary risk factors such as
Dyslipidaemia , smoking and a family history of coronary
artery disease were present in both groups and were not
responsible for the higher incidence of SMI seen. De Luca
et al33 showed that incidence of silent ischaemia increases
with poor blood glucose control however in our sample
none of the diabetics had evidence of proteinuria and
diabetic retinopathy -indicating that our sample comprised
of a low risk group of type 2 diabetics. The higher frequency
of silent ischaemia seen in the diabetic group (19%) could
have been explained by the higher proportion of diabetics
having coronary risk factors but statistical significance
(p=0.397) could not be established. More work needs to be
done on the subject preferably with a more sensitive
screening test such as stress myocardial imaging for some
definitive answers. 
In our study female patients showed very low
incidence of silent ischaemia (2 out of 28) this may be
because most of the female subjects included in the study
were below 45 years of age. In this period women are
naturally protected against atherosclerotic coronary artery
disease as shown by Barret. et al.34
Conclusion
With the results of our cross sectional study we
found that the frequency of silent myocardial ischaemia was
not significantly different in diabetics as compared to non-
diabetic subjects in this cohort-despite the greater
prevalence of hypertension in the diabetic group. However
more studies from this region are required as many
attributes of diabetes complications are different from that
reported from Western countries, due to different population
characteristics.
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